학술논문
'학술논문'
에서 검색결과 37건 | 목록
1~10
Report
Duke University; Metro Health, Michigan; National Heart, Lung, and Blood Institute (NHLBI); University Hospitals Cleveland Medical Center; University of Washington
Okeke NL, Webel AR, Bosworth HB, Aifah A, Bloomfield GS, Choi EW, Gonzales S, Hale S, Hileman CO, Lopez-Kidwell V, Muiruri C, Oakes M, Schexnayder J, Smith V, Vedanthan R, Longenecker CT. Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD). Am Heart J. 2019 Oct;216:91-101. doi: 10.1016/j.ahj.2019.07.005. Epub 2019 Jul 18.
Assess and Adapt to the Impact ofCOVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV
Assess and Adapt to the Impact of
Report
Hospital st pierre, Belgium; University of Athens; University of Cape Town; Hospital General Universitario Gregorio Marañon; Hospital Sant Joan de Deu; Karolinska Institutet; Great Ormond Street Hospital for Children NHS Foundation Trust; Guy's and St Thomas' NHS Foundation Trust; North Manchester General Hospital (Northern Care Alliance NHS Group), Manchester; University Hospital Birmingham NHS Foundation Trust; Imperial College Healthcare NHS Trust; King's College Hospital NHS Trust; St George's University Hospitals NHS Foundation Trust; CHIPS+ cohort; Medical Research Council
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV -2 Antibody Study Protocol
Academic Journal
Díaz, Natalia A.; de Miguel, Rosa; Agüero, Fernando; Sued, Omar; Arribas, José R.; Ambrosioni, Juan; the Hospital Clinic COVID-19 in HIV Investigators; Blanco, José L.; de la Mora, Lorena; García-Alcaide, Felipe; González-Cordón, Ana; Inciarte, Alexis; Laguno, Montserrat; Leal, Lorna; Martínez-Chamorro, Esteban; Martínez-Rebollar, María; Miró, José M.; Rojas, Jhon F.; Torres, Berta; Mallolas, Josep
Infectious Diseases & Therapy; Feb2022, Vol. 11 Issue 1, p1-13, 13p
Report
MRC Clinical Trials Unit at UCL; Centre Hospitalier Universitaire Saint Pierre; German Pediatric and Adolescent HIV Cohort (GEPIC), GERMANY; Greece Cohort, GREECE; Register for HIV infection in children, ITALY; ATHENA ,THE NETHERLANDS; Polish Paediatric Cohort, POLAND; HSM/CHLN Lisbon, PORTUGAL; Centro Hospitalar do Porto; Victor Babes Hospital Cohort, Bucharest, ROMANIA; Republican Hospital of Infectious Diseases, St Petersburg, RUSSIA; Irkutsk AIDS Centre, RUSSIA; The City HIV Centre, St Petersburg, RUSSIA; CoRISpe-cat cohort of HIV-infected children, SPAIN; CoRISpe-S cohort of HIV-infected children, SPAIN; Karolinska Institutet; Swiss Mother and Child HIV Cohort Study, SWITZERLAND; Programs for HIV Prevention and Treatment (PHPT), THAILAND; National Surveilliance of HIV in Pregnancy and Childhood and Collaborative HIV Paediatric Study (CHIPS); Collaborative HIV Paediatric Study (CHIPS); Ukraine Paediatric HIV Cohort, UKRAINE
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC): Paediatric Protocol
Report
ERASE - Rise Against Malaria Project - Support for Malaria Prevention, Diagnosis and Treatment in the Context of the Covid-19 Pandemic Among Pregnant Women in Northern Uganda: a Prospective Observational Study
Report
Asociacion Benefica Prisma; Universidad Peruana Cayetano Heredia; Johns Hopkins Bloomberg School of Public Health
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
Report
Convalescent Plasma Transfusion Therapy in Severe COVID-19 Patients- a Tolerability, Efficacy and Dose-response Phase II RCT
Report
Evaluation of Antigen Rapid Diagnostic Tests (Ag-RDTs) for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV -2) in Kiambu County, Kenya
Report
Ivermectin Versus Standard Treatment in Mild COVID-19 : a Prospective Cohort Study.
Report
Universal Medical College Hospital, Bangladesh; Green Life Center for Rheumatic Care & Research, Bangladesh; Incepta Pharmaceuticals Ltd, Bangladesh
van Schouwenburg PA, van de Stadt LA, de Jong RN, van Buren EE, Kruithof S, de Groot E, Hart M, van Ham SM, Rispens T , Aarden L, Wolbink GJ, Wouters D. Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation. Ann Rheum Dis. 2013 Jan;72(1):104-9. doi: 10.1136/annrheumdis-2012-201445. Epub 2012 Jul 3.
Jani RH, Gupta R, Bhatia G, Rathi G, Ashok Kumar P, Sharma R, Kumar U, Gauri LA, Jadhav P, Bartakke G, Haridas V, Jain D, Mendiratta SK. A prospective, randomized, double-blind, multicentre, parallel-group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC-3197) and adalimumab (Humira) in patients with rheumatoid arthritis. Int J Rheum Dis. 2016 Nov;19 (11):1157-1168. doi: 10.1111/1756-185X.12711. Epub 2015 Jul 14.
Jamshidi A, Gharibdoost F, Vojdanian M, Soroosh SG, Soroush M, Ahmadzadeh A, Nazarinia MA, Mousavi M, Karimzadeh H, Shakibi MR, Rezaieyazdi Z, Sahebari M, Hajiabbasi A, Ebrahimi AA, Mahjourian N, Rashti AM. A phaseIII , randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA(R)) to the reference product (Humira(R)) in patients with active rheumatoid arthritis. Arthritis Res Ther. 2017 Jul 20;19 (1):168. doi: 10.1186/s13075-017-1371-4.
A Prospective, Randomized, Double Blind, Active Controlled Study to Compare PK & Safety of Biosimilar Adalimumab (Advixa) 40 mg/ 0.4 ml of Incepta Pharmaceuticals Ltd. With Humira 40 mg/ 0.4ml of Abbvie Ltd. in Healthy, Adult,Human Subject by Single Subcutaneous Injection Followed by Efficacy & Safety Study in Patients With Rheumatoid Arthritis
Jani RH, Gupta R, Bhatia G, Rathi G, Ashok Kumar P, Sharma R, Kumar U, Gauri LA, Jadhav P, Bartakke G, Haridas V, Jain D, Mendiratta SK. A prospective, randomized, double-blind, multicentre, parallel-group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC-3197) and adalimumab (Humira) in patients with rheumatoid arthritis. Int J Rheum Dis. 2016 Nov;
Jamshidi A, Gharibdoost F, Vojdanian M, Soroosh SG, Soroush M, Ahmadzadeh A, Nazarinia MA, Mousavi M, Karimzadeh H, Shakibi MR, Rezaieyazdi Z, Sahebari M, Hajiabbasi A, Ebrahimi AA, Mahjourian N, Rashti AM. A phase
A Prospective, Randomized, Double Blind, Active Controlled Study to Compare PK & Safety of Biosimilar Adalimumab (Advixa) 40 mg/ 0.4 ml of Incepta Pharmaceuticals Ltd. With Humira 40 mg/ 0.4ml of Abbvie Ltd. in Healthy, Adult,
검색 결과 제한하기
제한된 항목
[검색어] the Hospital Clinic COVID-19 in HIV Investigators
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어